Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOMAGHI: Magnesium Sulfate in Rapid Atrial Fibrillation
NCT00965874Phase 3Completed
- Sponsor
- Université de Monastir
- Start
- Nov 2009
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in Atrial fibrillation (AFib) (3 arms), sponsored by Université de Monastir. Primary endpoint: Heart Rate < 90 bpm or 20% reduction from baseline at 24 hours. Started Nov 2009; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00965874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965874.